Taro Pharmaceutical Industries Ltd $141.26

down -4.07


31/7/2014 04:05 PM  |  : TARO  
Industries :
Get Trend Analysis Icon Get TARO Trend Analysis - it has outperformed the S&P 500 by 106%

Partner Headlines

  1. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  2. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  3. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  4. Novo, Other Medicals Display Healthy Action

    IBD
  5. Pharmaceutical Industry on the Cusp Of Change

    GuruFocus
  6. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  7. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  8. Caesarstone, Check Point Show Strong Fundamentals

    IBD
  9. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  10. Ascending Bases Are Rare, But Can Spark Big Gains

    IBD
  11. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  12. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  13. Actavis, Perrigo Pace Strong Generic Drugs Group

    IBD
  14. Top Funds Like Facebook And Health Care Stocks

    IBD
  15. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  16. US Stock Futures Up Ahead Of Pending Home Sales

    Benzinga
  17. Taro Commences Tender Offer to Buybackup Up to $200M of Ordinary Shares ...

    Benzinga
  18. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  19. UPDATE: Credit Suisse Initiates Coverage on Taro Pharmaceutical on Market ...

    Benzinga
  20. Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm

    IBD
  21. Actavis, Warner Chilcott Take Another Step Forward

    IBD
  22. Taro to Defer Annual General Meeting to September 12, 2013

    Benzinga
  23. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  24. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  25. Generic Drugs: Watson Up, Impax Awaits FDA Decision

    IBD
  26. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  27. BlueMountain Capital Says Shareholders of Taro Should Reject Sun Offer

    Benzinga
  28. Taro Special Committee Rejects Proposal from Sun Pharma

    Benzinga
  29. Taro Pharmaceutical Shareholder, Guardian Point Capital, Issues Letter ...

    Benzinga
  30. Mellanox, Several Other Israeli Stocks Show Strength

    IBD
  31. Taro Special Committee Continues to Evaluate Sun Pharma's Proposal to Acquire ...

    Benzinga
  32. IsZo Capital Calls upon Special Committee of Taro Pharmaceutical to Reject ...

    Benzinga
  33. Israel's Best-Rated Stocks Show Growth Plenty Of Problems

    IBD
Trading Center